Oncopharmpod
New FDA approved indications for lenvatinib, pembro, and apalutamide
- Author: Vários
- Narrator: Vários
- Publisher: Podcast
- Duration: 0:16:35
- More information
Informações:
Synopsis
Discussion of FDA's approval of lenvatinib & pembrolizumab for endometrial cancer followed by a comparison of TITAN v. ENZAMET prompted by apalutamide's latest approval.
